Aratana Therapeutics Inc (fka PETX)

[terry hallinan]

Aratana Therapeutics (PETX)

Engaged Capital bought 842,312 shares of the pet therapeutics company from July 31 through August 7 at prices ranging from $4.22 to $4.98 per share, increasing its stake to 3,242,312 shares or 6.8% of the outstanding stock.

Engaged had entered into a cooperation agreement with the issuer in May, with the company agreeing to appoint two designees of Engaged to its board and establish an ad hoc strategic review committee.

from Dow Jones as reported by broker 8/10/18

I am less than enthusiastic about the fact. There was futile resistance by PETX.

My own worthless opinion is that while the news may attract more new buyers the relationship is not likely salubrious longer term.

Best, Terry